CN1331519C - Calculi resolving capsule and its preparing method - Google Patents
Calculi resolving capsule and its preparing method Download PDFInfo
- Publication number
- CN1331519C CN1331519C CNB2004100280668A CN200410028066A CN1331519C CN 1331519 C CN1331519 C CN 1331519C CN B2004100280668 A CNB2004100280668 A CN B2004100280668A CN 200410028066 A CN200410028066 A CN 200410028066A CN 1331519 C CN1331519 C CN 1331519C
- Authority
- CN
- China
- Prior art keywords
- radix
- calculi
- stir
- rice flour
- resolving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a calculi resolving capsule which is mainly used for treating urinary system calculi, liver calculi and cholelithiasis. The scientific formula comprising Chicken's Gizzard membrane, Japanese climbing fern spore, stir-baked squama manitis, longhairy antenoron herb, lalang grass rhizome, fructus liquidambaris, baked rice flour, grassleaf sweetflag rhizome, honey-fried radix achyranthis bidentatae, cicada slough, talcum powder, milkvetch root, tangshen, radix glycyrrhiza, etc. are adopted to prepare capsules. The calculi resolving capsule has the advantages of few drug consumption, short treatment course, obvious effect, and no operation pain, toxic effect or side effect, can be conveniently taken, has the action of calculi regeneration prevention and realizes the efficiency of humid heat clearing, and calculi resolving and discharging by the regulation and the promotion of Chinese patent medicine.
Description
Technical field
The present invention relates to a kind of traditional Chinese medical science prescription, referring in particular to a kind of is the treatment urinary system calculus of feedstock production and the Chinese patent medicine fossil capsule of liver and bile stone with the Chinese herbal medicine, the invention still further relates to the preparation method of this medicine.
Background technology
Urinary system calculus is a kind of clinical disease of harm humans health, is meant a kind of calculus that occurs in kidney, ureter, bladder position.Early on the books in China's TCM Document, " stranguria caused by urinary stone " by name." General Treatise on the Cause and Symptoms of Diseases " cloud: the stranguria caused by urinary stone person, drench and go out stone also.Kidney master water, water is tied and is then turned to stone, so kidney visitor sandstone is suffered from a deficiency of the kidney and taken advantage of by heat, heat then for drenching, urinate and then lead in the stem by the shape of its disease, urinating not, energy rate goes out.Treat urinary system calculus and liver and bile stone at present, doctor trained in Western medicine is main means with symptomatic treatment, operation, rubble, the misery for the moment when symptomatic treatment only can solve the emergency case outbreak, and calculus still is stored in patient's body; Surgical calculus removing has misery, bear the complication that may cause after certain dangerous and operation, and be not suitable for silt shape calculus patient; Must lean on practicable lithodialysis, calculus measure to guarantee the success of rubble behind the rubble.Though the liver and bile stone of treatment operation at present is main means with the excision gallbladder still, but easily cause the fat digestion obstacle behind the excision gallbladder, fat-soluble avitaminosis, pressure of biliary tract increases and the increase of biliary tract infection probability causes recurrence of hepatolithiasis, and western medicine therapy can not fundamentally solve lithogenous reason, even therefore many patients are through still forming calculus easily in the body behind the operative treatment.
In addition, as oral lithagogue liquid, uralyt, excellent clone etc., all be in the Western medicine of existing treatment calculus cholelithiasis and urinary system calculus unification treatment, both obscure mutually, curative effect is not single-minded, and unsatisfactory curative effect, and drug dose is big, onset is slow, pain relieving, antiinflammatory, diuresis are poor.Some lithagogue infusions and for example, dose, ingredient and pharmacological action curative effect in its prescription are not good enough.Though cholelithiasis is logical, XIAOYAN LIDAN PIAN, king's oral lithagogue liquid effective to cholecystitis, cure rate is low, calculus of bile duct in the gallbladder is not had obvious curative effects, and human body is had side effects, and does not have to protect the liver and protects cholic effect, costs an arm and a leg, the patient is difficult for receiving.
Theory of Chinese medical science thinks that urinary system calculus regulating liver-QI gallstone disease is because " emotionally disturbed, disorder of emotion, depression of liver-QI; qi stagnation blood stasis; alluvial is condensed " calculus forms because of majority, therefore, provides a kind of Chinese patent medicine fat fat-reducing of dispelling that can " depressed liver-energy dispersing and QI regulating; eliminating blood stasis and smoothing collaterals; spleen reinforcing is good for the stomach, anti-inflammatory and choleretic ", unobstructed tube chamber, the lithodialysis Sal Nitri, thus reach the purpose of preventing and treating urinary system calculus and liver and bile stone.
Summary of the invention
The object of the present invention is to provide a kind of Chinese patent medicine fat fat-reducing of dispelling that can " spleen reinforcing is good for the stomach for depressed liver-energy dispersing and QI regulating, eliminating blood stasis and smoothing collaterals, anti-inflammatory and choleretic ", unobstructed tube chamber, the softening the hard mass lithodialysis, diuresis and expelling stone, thus reach the purpose of prevention and treatment urinary system calculus and liver and bile stone.
The present invention also provides fossil capsular manufacture method.
The capsular side's medicine of fossil of the present invention consists of: Endothelium Corneum Gigeriae Galli, Spora Lygodii, stir-baked SQUAMA MANITIS, Herba Lysimachiae, Rhizoma Imperatae, Fructus Liquidambaris, parched rice flour, Rhizoma Acori Graminei, Radix Acanthopanacis Bidentatae (processed), Periostracum Cicadae, Pulvis Talci, the Radix Astragali, Radix Codonopsis and Radix Glycyrrhizae.
The capsular manufacture method of fossil of the present invention comprises the steps:
At first, the pressure furnace steaming and decocting that Endothelium Corneum Gigeriae Galli, Spora Lygodii, stir-baked SQUAMA MANITIS, Herba Lysimachiae, Rhizoma Imperatae, Fructus Liquidambaris, Rhizoma Acori Graminei, Radix Acanthopanacis Bidentatae (processed), Periostracum Cicadae, the Radix Astragali, Radix Codonopsis and the Radix Glycyrrhizae of described proportioning is put in the steam oven simultaneously becomes fluid extract;
Then, the fluid extract after making with after 10% Pulvis Talci, 12% parched rice flour as additional material fully mixes, is delivered to the steam oven dehumidifier and become dried cream;
At last, dried cream powder is incapsulated after broken, preserve standby behind the package encapsulation.
Compare with treatment means with the prescription of existing treatment urinary system calculus and liver and bile stone, fossil capsule of the present invention selects medicine composition near pathological change, little through clinical proof dosage, short treating period takes effect obviously the misery of need not performing the operation, taking convenience, have no side effect, and play the regenerated effect of prevention calculus, promote to reach the effect of eliminating damp-heat, calculus dissolving and excreting with the Chinese patent medicine conditioning.And its production method is easy, is suitable for volume production, also is suitable for oneself to join prescription self-control medicament.
The specific embodiment
The capsular side's medicine of fossil of the present invention consists of: Endothelium Corneum Gigeriae Galli, Spora Lygodii, stir-baked SQUAMA MANITIS, Herba Lysimachiae, Rhizoma Imperatae, Fructus Liquidambaris, parched rice flour, Rhizoma Acori Graminei, Radix Acanthopanacis Bidentatae (processed), Periostracum Cicadae, Pulvis Talci, the Radix Astragali, Radix Codonopsis and Radix Glycyrrhizae.
Each formulation ratio (weight ratio) is as follows:
Endothelium Corneum Gigeriae Galli 10% Spora Lygodii 4% stir-baked SQUAMA MANITIS 4% Herba Lysimachiae 10%
Rhizoma Imperatae 10% Fructus Liquidambaris 3% Rhizoma Acori Graminei 3% Radix Acanthopanacis Bidentatae (processed) 4%
Periostracum Cicadae 5% Pulvis Talci 10% Radix Astragali 10% Radix Codonopsis 10%
Radix Glycyrrhizae 5% parched rice flour 12%
The side separates: be monarch with the Endothelium Corneum Gigeriae Galli, has the effect of softening the hard mass litholytic, the Radix Astragali and Radix Codonopsis are minister, and with strengthening the body resistance, QI invigorating is enriched blood, gas lift then water falls, and can dredge urinary catheter by promoting blood circulation, and Herba Lysimachiae, Rhizoma Imperatae, Fructus Liquidambaris, Spora Lygodii, Rhizoma Acori Graminei, Talcum, Radix Acanthopanacis Bidentatae (processed), stir-baked SQUAMA MANITIS have the effect of being good at penetrating, and it is stronger that the medicament of dissolving calculus and inducing diuresis for treating stranguria syndrome share effectiveness, make that dissolving calculus and calculus are more sure, admittedly be adjuvant drug.Radix Glycyrrhizae have the title of guiding drug, can make each medicament sick institute that goes directly, and can be decided to be messenger drug.
Endothelium Corneum Gigeriae Galli is the good medicine of strengthening the spleen to promote digestion, can control accumulation of food in the stomach and intes tine due to indigestion and can the astringency inducing reducing urination and control the enuresis and urine is on the point of number, and is effective good medicine of treatment calculus, and property sweet-puckery flavor, flat is gone into spleen, stomach, urinary bladder channel, is mainly used in diseases such as kidney, bladder and liver and gall road calculus.
Spora Lygodii is for specializing in the tonneau water channel, stranguria pain, and nature and flavor are sweet salty-cold, go into bladder small intestine meridian.Sweet light diuresis, inducing diuresis for treating stranguria syndrome, be used for stranguria marked by chyluria, stranguria caused by urinary stone, sand Stranguria (calculus of urethra), pyretic stranguria diseases such as (urinary tract infections).
Squama Manis has another name called stir-baked SQUAMA MANITIS, has penetrance, can reach the through ailing place of meridians thoroughly, and nature and flavor become, are slightly cold, and go into liver, kidney channel.
Radix Acanthopanacis Bidentatae (processed) is specialized in stranguria with blood, pyretic stranguria, hematuria, Urethra astringent pain and lumbago etc., and nature and flavor hardship, acid, flat are gone into liver, kidney channel, be good at descending, can the promoting blood circulation to restore menstrual flow arteries and veins, inducing diuresis for treating stranguria syndrome.
The special clinically treating the liver of Herba Lysimachiae, gallbladder, kidney, bladder, ureteral calculus, nature and flavor are sweet, light, flat, go into liver, kidney channel, urinary bladder channel, are applicable to diseases such as sand Stranguria, stranguria caused by urinary stone, the puckery pain of urine and jaundice.Herba Lysimachiae can make urine become acidity when the treatment vesical calculus, and impel the calculus that is present under the alkaline environment to obtain dissolving, in addition, Herba Lysimachiae also has choleretic effect, promote the hepatocyte secretion, bile increases intrinsic pressure increasing in the hepatic duct, be beneficial to bile and discharge, the litholysis in the hepatic duct can be discharged.
Can the clear away heart-fire heat of lung stomach of Rhizoma Imperatae, removing heat from blood promotes the production of body fluid, and is sweet in flavor and cold in property, goes into the heart, lung, stomach, urinary bladder channel, is applicable to diseases such as hematuria, pyretic stranguria, edema.
But Fructus Liquidambaris promoting the circulation of QI to alleviate the stagnation in middle-JIAO, promoting blood circulation to remove obstruction in the collateral, inducing diuresis to remove edema mostly are circulation of qi promoting, spleen invigorating, diuretic clinically and make it medicine for assistant.
Radix Glycyrrhizae can be pacified and careless stone and separate hundred poison, rises to be in harmonious proportion the effect of each medicine, and makes each medicine sick institute that goes directly for guiding drug.
Radix Astragali energy tonifying Qi and lifting yang, strengthening superficial resistance to stop perspiration, qi-supplementing, blood-engendering, effect sweet in flavor and warm in property, as to have hair growth promoting.
Radix Codonopsis energy QI invigorating enriching blood and promoting secretion of body fluid, not dry oiliness, nature and flavor are sweet flat, are good at the spleen reinforcing nourishing the stomach, gas in the strong fortune, the gas of kind tonifying five ZANG-organs is for controlling the principal agent of the deficiency of vital energy.
Pulvis Talci can be controlled five types of stranguria, and heat clearing away and restlessness relieving is controlled stranguria caused by urinary stone partially, goes into stomach, urinary bladder channel, inducing diuresis for treating stranguria syndrome.
Periostracum Cicadae has the effect of ascending the clear and descending the turbid.
Usage and dosage is as follows:
Every day 3 times, each 4-5 grain, the assault amount can be obeyed 6 at every turn, take medicine after the meal, and every day the polydipsia boiled water, strengthen urinating to play percussion.
The course of treatment: 20 days is a course of treatment, and conventional clothes were checked after 3 courses of treatment.
The capsular manufacture method of fossil of the present invention is as follows:
At first, the pressure furnace steaming and decocting that Endothelium Corneum Gigeriae Galli, Spora Lygodii, stir-baked SQUAMA MANITIS, Herba Lysimachiae, Rhizoma Imperatae, Fructus Liquidambaris, Rhizoma Acori Graminei, Radix Acanthopanacis Bidentatae (processed), Periostracum Cicadae, the Radix Astragali, Radix Codonopsis and the Radix Glycyrrhizae of above proportioning is put in the steam oven simultaneously becomes fluid extract;
Then, the fluid extract after making with after 10% Pulvis Talci, 12% parched rice flour as additional material fully mixes, is delivered to the steam oven dehumidifier and become dried cream;
At last, capsule that dried cream powder is packed into No. 0 after broken, the every capsules of packing is 0.25 gram, preserves standby behind the package encapsulation.
Above disclosed is the preferred embodiment of fossil capsule of the present invention and manufacture method thereof only, can not limit the present invention's interest field certainly with this, and therefore the equivalent variations of being done according to the present patent application claim still belongs to the scope that the present invention is contained.
Claims (2)
1. fossil capsule is characterized in that prescription comprises: Endothelium Corneum Gigeriae Galli, Spora Lygodii, stir-baked SQUAMA MANITIS, Herba Lysimachiae, Rhizoma Imperatae, Fructus Liquidambaris, Rhizoma Acori Graminei, Radix Acanthopanacis Bidentatae (processed), Periostracum Cicadae, the Radix Astragali, Radix Glycyrrhizae, Pulvis Talci, parched rice flour and Radix Codonopsis, formulation weight are such as down:
Endothelium Corneum Gigeriae Galli 10% Spora Lygodii 4% stir-baked SQUAMA MANITIS 4% Herba Lysimachiae 10%
Rhizoma Imperatae 10% Fructus Liquidambaris 3% Rhizoma Acori Graminei 3% Radix Acanthopanacis Bidentatae (processed) 4%
Periostracum Cicadae 5% Radix Astragali 10% Radix Codonopsis 10% Radix Glycyrrhizae 5%
Pulvis Talci 10% parched rice flour 12%.
2. the capsular manufacture method of a kind of fossil according to claim 1 is characterized in that:
At first, the pressure furnace steaming and decocting that Endothelium Corneum Gigeriae Galli, Spora Lygodii, stir-baked SQUAMA MANITIS, Herba Lysimachiae, Rhizoma Imperatae, Fructus Liquidambaris, Rhizoma Acori Graminei, Radix Acanthopanacis Bidentatae (processed), Periostracum Cicadae, the Radix Astragali, Radix Codonopsis and the Radix Glycyrrhizae of described proportioning is put in the steam oven simultaneously becomes fluid extract;
Then, the fluid extract after making with after 10% Pulvis Talci, 12% parched rice flour as additional material fully mixes, is delivered to the steam oven dehumidifier and become dried cream;
At last, dried cream powder is incapsulated after broken, preserve standby behind the package encapsulation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100280668A CN1331519C (en) | 2004-07-14 | 2004-07-14 | Calculi resolving capsule and its preparing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100280668A CN1331519C (en) | 2004-07-14 | 2004-07-14 | Calculi resolving capsule and its preparing method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1720926A CN1720926A (en) | 2006-01-18 |
CN1331519C true CN1331519C (en) | 2007-08-15 |
Family
ID=35911762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100280668A Expired - Fee Related CN1331519C (en) | 2004-07-14 | 2004-07-14 | Calculi resolving capsule and its preparing method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1331519C (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104491206A (en) * | 2015-01-15 | 2015-04-08 | 王金强 | Traditional Chinese medicine preparation for treating calculus of bile duct and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1174051A (en) * | 1997-05-07 | 1998-02-25 | 陈圣运 | Medicine for lithiasis |
CN1219409A (en) * | 1997-12-10 | 1999-06-16 | 叶章照 | Traditional Chinese medicine for curing psoriasis |
-
2004
- 2004-07-14 CN CNB2004100280668A patent/CN1331519C/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1174051A (en) * | 1997-05-07 | 1998-02-25 | 陈圣运 | Medicine for lithiasis |
CN1219409A (en) * | 1997-12-10 | 1999-06-16 | 叶章照 | Traditional Chinese medicine for curing psoriasis |
Also Published As
Publication number | Publication date |
---|---|
CN1720926A (en) | 2006-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103099959B (en) | Traditional Chinese medicine preparation for treating ulcerative colitis and preparation method thereof | |
CN100998843A (en) | Medicinal composition for treating cholecystitis | |
CN101862428B (en) | Chinese medicament for treating benign prostatic hyperplasia | |
CN105169214A (en) | Traditional Chinese medicine composition for treating atherosclerosis, and preparation method thereof | |
CN102357177B (en) | Traditional Chinese medicine for curing climacteric metancholia | |
CN101732602B (en) | Medicament for treating calculi and preparation method thereof | |
CN101234184B (en) | Orally-administered Chinese medicine composition for treating radiation proctitis | |
CN110302332A (en) | A kind of Chinese medicine composition and preparation method thereof for treating intestinal cancer | |
CN104524190A (en) | Medicament for treating rheumatic lumbar disease and preparation method thereof | |
CN1331519C (en) | Calculi resolving capsule and its preparing method | |
CN103585585A (en) | Traditional Chinese medicine composition for treating choledocholithiasis and preparation method thereof | |
CN102908580B (en) | Traditional Chinese medicine composition for treating woman metrorrhagia and preparation method of traditional Chinese medicine composition | |
CN105362914A (en) | Traditional Chinese medicinal composition for treating chronic gastritis | |
CN104758754A (en) | Medicine for treating kidney qi deficiency benign prostate hyperplasia and preparation method thereof | |
CN105031505A (en) | Medicine for treating benign prostatic hyperplasia hypertrophy and preparation method thereof | |
CN104971332A (en) | Traditional Chinese medicine for treating hemorrhoids | |
CN102240384B (en) | Medicament for treating phlegm-stasis accumulating type epilepsy and preparation method thereof | |
CN101972317B (en) | Medicament for treating fallopian tube obstructive infertility | |
CN101658648B (en) | Medicament for treating cervical erosion | |
CN106310082A (en) | Kidney-tonifying traditional Chinese medicine composition and preparation method thereof | |
CN105412883A (en) | Traditional Chinese medicine composition for treating chronic bronchitis | |
CN105169111A (en) | Traditional Chinese medicine composition for treating chronic urticaria and application of traditional Chinese medicine composition | |
CN105288473A (en) | Traditional Chinese medicine composition for treating lupus erythematosus and application thereof | |
CN105727155A (en) | Traditional Chinese medicinal prescription for preventing and treating hepatitis A and preparation method of traditional Chinese medicinal prescription | |
CN103405555B (en) | Preparation method of bowel clearing granules before urinary surgery endoscopic operation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |